BioSpace News Archive

Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced it is highlighting recently-launched products in high growth segments of joint preservation and restoration from its Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions businesses during the 2024 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting on February 13-15 in San Francisco, CA.

BioXcel Therapeutics, Inc. today announced that it has terminated its proposed public offering of $60.0 million of shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock, previously announced on February 8, 2024.

Trinity Biotech Plc. announced that it plans to change the ratio of the American depositary shares representing its Class A ordinary shares from one ADS representing four Class A ordinary share to one ADS representing twenty Class A ordinary shares.

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the “Company” or “Telo”) is pleased to announce that it has received the first patient sample for its clinical trial monitoring multiple myeloma (“MM”) disease progression in post-treated patients.

Revelation Biosciences Inc. announced today that, as part of a limited number of accepted abstract authors, the company was invited to give an oral presentation of new preclinical data on the potential therapeutic benefit of Gemini for the prevention of acute kidney injury (AKI) at The 29th International Conference on Advances in Critical Care Nephrology taking place in San Diego from March 12-15, 2024.

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2023 financial results on Tuesday, February 27, 2024, after the market close.

Cloud DX, a leading North American provider of virtual care and remote patient monitoring platforms is pleased to announce a new Partnership Agreement with New York-based Sanrai International.